Therefore, activating the PI3K-Akt/PKB signaling, which in turn affects the insulin signaling pathway, and finally can improve cognitive function due to disorders of energy metabolism, may be a potential pathway for ginsenoside CK to inhibit AD [203]. The gene discussed is AKT1; the disease is Alzheimer disease.